News chronological

Showing 10 items before 1159391

Filters Applied:

NPR (Bobby Allyn) - Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'

Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.

Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.Open

AXIOS (Nathan Bomey) - Why JPMorgan Chase CEO Jamie Dimon isn't sweating private credit

JPMorgan Chase CEO Jamie Dimon downplayed the threat of a private credit meltdown , while Goldman Sachs signaled that its private credit business is in good shape. Why it matters: The trend of investors exiting private credit funds has raised concerns that a blowup in nonbank lending could infect the broader financial markets. The big picture: Dimon noted Monday in his annual letter to shareholders that the leveraged private credit market totals $1.8 trillion, while investment-grade bonds total $13 trillion and residential mortgage securities and loans also total $13 trillion. - "In the great scheme of things, private credit probably does not present a systemic risk," Dimon wrote. Zoom in: His comments came on the same day that Goldman…

JPMorgan Chase CEO Jamie Dimon downplayed the threat of a private credit meltdown , while Goldman Sachs signaled that its private credit business is in good shape. Why it matters: The trend of investors exiting private credit funds has raised concerns that a blowup in nonbank lending could infect the broader financial markets. The big picture: Dimon noted Monday in his annual letter to shareholders that the leveraged private credit market totals $1.8 trillion, while investment-grade bonds total $13 trillion and residential mortgage securities and loans also total $13 trillion. - "In the great scheme of things, private credit probably does not present a systemic risk," Dimon wrote. Zoom in: His comments came on the same day that Goldman…Open